• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Bioelectrochemistry . Advancement in SARS-CoV-2 diagnosis: A new and stable electrochemical biosensor for genomic RNA detection

tetano

Editor, Senior Moderator
Bioelectrochemistry


. 2024 Aug 17:161:108798.
doi: 10.1016/j.bioelechem.2024.108798. Online ahead of print. Advancement in SARS-CoV-2 diagnosis: A new and stable electrochemical biosensor for genomic RNA detection

José A L Gomide[SUP] 1 [/SUP], Anna C R Moço[SUP] 1 [/SUP], Leonardo T R Tanaka[SUP] 1 [/SUP], Maikon R A Alexandre[SUP] 2 [/SUP], Tárcio Peixoto Roca[SUP] 3 [/SUP], Deusilene Souza Vieira Dall'acqua[SUP] 3 [/SUP], Márcia M Costa Nunes Soares[SUP] 4 [/SUP], Ronaldo J Oliveira[SUP] 5 [/SUP], Renata C Lima[SUP] 2 [/SUP], João M Madurro[SUP] 6 [/SUP], Ana G Brito-Madurro[SUP] 7 [/SUP]



Affiliations
Abstract

Coronavirus disease (COVID-19) is caused by infection with the SARS-CoV-2 virus, having already caused more than seven million deaths worldwide. Conventional techniques for SARS-CoV-2 detection have limitations, as high cost, low specificity, and longer analysis time, among others. Biosensors emerge as a necessary alternative to overcome the difficulties of current diagnostics. This paper reports a sensor platform where silver-doped zinc oxide nanomaterial (Ag:ZnONp) was used onto carbon screen-printed electrode and ethidium bromide as indicator for development of a specific electrochemical genosensor for COVID-19. This genosensor demonstrated good linearity between the concentrations of 5.62 × 10[SUP]4[/SUP]-5.62 copies/mL and a detection limit of 5 copies/mL with gRNA in patient's samples, with a response time within 30 min. Molecular modeling and morphological analysis are in agreement with obtained electrochemical results. Additional techniques such as AFM, SEM, and EIS were conducted to characterize the morphological and electrochemical properties of the biosensor's surface. The biosensor was also capable of detecting the target presence in spiked samples and demonstrated a stability of 60 days, higher than other similar biosensors for SARS-CoV-2.

Keywords: Electrochemistry; Ethidium bromide; Genosensor; Point-of-care; SARS-CoV-2; Sensitivity.

 
Back
Top Bottom